Journal of Experimental & Clinical Cancer Research(@JournalofExper1) 's Twitter Profileg
Journal of Experimental & Clinical Cancer Research

@JournalofExper1

Official journal of "Regina Elena" National Cancer Institute
https://t.co/hL7ytcADtP

ID:1218124828454113283

linkhttps://go.sn.pub/jcjmdK calendar_today17-01-2020 10:56:34

2,3K Tweets

518 Followers

972 Following

Journal of Experimental & Clinical Cancer Research(@JournalofExper1) 's Twitter Profile Photo

Look here๐Ÿ‘‡

METTL3 recruiting M2-type immunosuppressed macrophages by targeting -SNAIL-CXCL2 axis to promote pulmonary metastasis

For free๐Ÿ’ป
jeccr.biomedcentral.com/articles/10.11โ€ฆ



Look here๐Ÿ‘‡ METTL3 recruiting M2-type immunosuppressed macrophages by targeting #m6A-SNAIL-CXCL2 axis to promote #colorectalcancer pulmonary metastasis For free๐Ÿ’ป jeccr.biomedcentral.com/articles/10.11โ€ฆ #Macrophages #Epithelialmesenchymaltransition #RNAmodification
account_circle
Pulmonary Cell News(@pulmonary_news) 's Twitter Profile Photo

Using different in vitro NSCLC models, researchers showed that NSCLC cells with low expression had increased malignant and invasive properties.

The Journal of Experimental & Clinical Cancer Research study comes from the University Medical Center Hamburg-Eppendorf's Wikman Lab: bit.ly/43YWyet

Using different in vitro NSCLC models, researchers showed that NSCLC cells with low #HERC5 expression had increased malignant and invasive properties. The @JournalofExper1 study comes from the University Medical Center Hamburg-Eppendorf's Wikman Lab: bit.ly/43YWyet
account_circle
Journal of Experimental & Clinical Cancer Research(@JournalofExper1) 's Twitter Profile Photo

Just published!๐Ÿพ

A paclitaxel-hyaluronan conjugate (ONCOFID-P-Bโ„ข) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the

Open access๐Ÿ”“
jeccr.biomedcentral.com/articles/10.11โ€ฆ



Just published!๐Ÿพ A paclitaxel-hyaluronan conjugate (ONCOFID-P-Bโ„ข) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the #tumormicroenvironment Open access๐Ÿ”“ jeccr.biomedcentral.com/articles/10.11โ€ฆ #Bladdercancer #Macrophages #Hyaluronicacid
account_circle
Journal of Experimental & Clinical Cancer Research(@JournalofExper1) 's Twitter Profile Photo

New!๐ŸŒธ

๐‡๐’๐๐€๐Ÿ’ ๐ฎ๐ฉ๐ซ๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐ข๐ง๐๐ฎ๐œ๐ž๐ฌ ๐ฏ๐ข๐š ๐€๐‹๐Š๐๐‡๐Ÿ“/๐‚๐ƒ๐Ÿ“๐Ÿ– ๐š๐ฑ๐ข๐ฌ ๐ข๐ง

Look hereโคต๏ธ
jeccr.biomedcentral.com/articles/10.11โ€ฆ

New!๐ŸŒธ ๐‡๐’๐๐€๐Ÿ’ ๐ฎ๐ฉ๐ซ๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐ข๐ง๐๐ฎ๐œ๐ž๐ฌ #๐ข๐ฆ๐ฆ๐ฎ๐ง๐ž๐ž๐ฏ๐š๐ฌ๐ข๐จ๐ง ๐ฏ๐ข๐š ๐€๐‹๐Š๐๐‡๐Ÿ“/๐‚๐ƒ๐Ÿ“๐Ÿ– ๐š๐ฑ๐ข๐ฌ ๐ข๐ง #๐ ๐š๐ฌ๐ญ๐ซ๐ข๐œ๐œ๐š๐ง๐œ๐ž๐ซ Look hereโคต๏ธ jeccr.biomedcentral.com/articles/10.11โ€ฆ #Immunotherapy
account_circle
Journal of Experimental & Clinical Cancer Research(@JournalofExper1) 's Twitter Profile Photo

Online!๐Ÿ’ป

GPR65 sensing tumor-derived lactate induces HMGB1 release from via the cAMP/PKA/CREB pathway to promote progression

Read here๐Ÿ‘‡
jeccr.biomedcentral.com/articles/10.11โ€ฆ


Online!๐Ÿ’ป GPR65 sensing tumor-derived lactate induces HMGB1 release from #TAM via the cAMP/PKA/CREB pathway to promote #glioma progression Read here๐Ÿ‘‡ jeccr.biomedcentral.com/articles/10.11โ€ฆ #Lactate #Tumorassociatedmacrophage
account_circle
Journal of Experimental & Clinical Cancer Research(@JournalofExper1) 's Twitter Profile Photo

New!โ›ณ๏ธ

TRF2 as novel marker of tumor response to -based therapy: from mechanistic insight to clinical implication

Look here๐Ÿ‘‡
jeccr.biomedcentral.com/articles/10.11โ€ฆ




New!โ›ณ๏ธ TRF2 as novel marker of tumor response to #taxane-based therapy: from mechanistic insight to clinical implication Look here๐Ÿ‘‡ jeccr.biomedcentral.com/articles/10.11โ€ฆ #BreastCancer #TelomericBindingFactor #Autophagy #DrugSensitivity
account_circle
Journal of Experimental & Clinical Cancer Research(@JournalofExper1) 's Twitter Profile Photo

New Review!๐ŸŽฏ

๐€ tug-of-war ๐›๐ž๐ญ๐ฐ๐ž๐ž๐ง ๐œ๐š๐ง๐œ๐ž๐ซ and ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ž ๐œ๐ž๐ฅ๐ฅ๐ฌ: ๐ซ๐ž๐œ๐ž๐ง๐ญ ๐š๐๐ฏ๐š๐ง๐œ๐ž๐ฌ ๐ข๐ง ๐ฎ๐ง๐ซ๐š๐ฏ๐ž๐ฅ๐ข๐ง๐  ๐ญ๐ก๐ž ๐จ๐ง๐ ๐จ๐ข๐ง๐  ๐›๐š๐ญ๐ญ๐ฅ๐ž

Enjoy!๐Ÿธ
jeccr.biomedcentral.com/articles/10.11โ€ฆ



New Review!๐ŸŽฏ ๐€ #๐ ๐ฅ๐ฎ๐ญ๐š๐ฆ๐ข๐ง๐ž tug-of-war ๐›๐ž๐ญ๐ฐ๐ž๐ž๐ง ๐œ๐š๐ง๐œ๐ž๐ซ and ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ž ๐œ๐ž๐ฅ๐ฅ๐ฌ: ๐ซ๐ž๐œ๐ž๐ง๐ญ ๐š๐๐ฏ๐š๐ง๐œ๐ž๐ฌ ๐ข๐ง ๐ฎ๐ง๐ซ๐š๐ฏ๐ž๐ฅ๐ข๐ง๐  ๐ญ๐ก๐ž ๐จ๐ง๐ ๐จ๐ข๐ง๐  ๐›๐š๐ญ๐ญ๐ฅ๐ž Enjoy!๐Ÿธ jeccr.biomedcentral.com/articles/10.11โ€ฆ #Metabolism #ImmuneCells #TumorMicroenvironment
account_circle
Journal of Experimental & Clinical Cancer Research(@JournalofExper1) 's Twitter Profile Photo

Featured Review๐Ÿ‘‡
๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐ฆ๐ž๐œ๐ก๐š๐ง๐ข๐ฌ๐ฆ๐ฌ ๐จ๐Ÿ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ž ๐œ๐ก๐ž๐œ๐ค๐ฉ๐จ๐ข๐ง๐ญ๐ฌ ๐๐ƒ-๐‹๐Ÿ ๐š๐ง๐ -๐Ÿ’ ๐ข๐ง ๐œ๐š๐ง๐œ๐ž๐ซ

Enjoy!
jeccr.biomedcentral.com/articles/10.11โ€ฆ



Featured Review๐Ÿ‘‡ ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐ฆ๐ž๐œ๐ก๐š๐ง๐ข๐ฌ๐ฆ๐ฌ ๐จ๐Ÿ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ž ๐œ๐ก๐ž๐œ๐ค๐ฉ๐จ๐ข๐ง๐ญ๐ฌ ๐๐ƒ-๐‹๐Ÿ ๐š๐ง๐ #๐‚๐“๐‹๐€-๐Ÿ’ ๐ข๐ง ๐œ๐š๐ง๐œ๐ž๐ซ Enjoy! jeccr.biomedcentral.com/articles/10.11โ€ฆ #CancerImmunotherapy #PDL1 #DrugIntervention
account_circle
Journal of Experimental & Clinical Cancer Research(@JournalofExper1) 's Twitter Profile Photo

New!๐Ÿ€

A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301)

Open access๐Ÿ”“
jeccr.biomedcentral.com/articles/10.11โ€ฆ




New!๐Ÿ€ A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301) Open access๐Ÿ”“ jeccr.biomedcentral.com/articles/10.11โ€ฆ #Fluorouracil #clinicaltrials #Cancertherapy #SolidTumor
account_circle
Journal of Experimental & Clinical Cancer Research(@JournalofExper1) 's Twitter Profile Photo

New study!๐Ÿน

A high-content screen of FDA approved drugs to enhance cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKCฮฑ activation

For freeโคต๏ธ
jeccr.biomedcentral.com/articles/10.11โ€ฆ


New study!๐Ÿน A high-content screen of FDA approved drugs to enhance #CART cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKCฮฑ activation For freeโคต๏ธ jeccr.biomedcentral.com/articles/10.11โ€ฆ #Tcell #Osteosarcoma
account_circle